Conference Call

cbdMD, Inc. will host an earnings call on February 17, 2026, to discuss Q1 2026 financial results and operational progress. The discussion will cover performance across their diverse product lines, including THC-free CBD, Delta-9, pet products, functional mushrooms, and their new THC-infused seltzer, Herbal Oasis. Investors will seek insights into their market strategy and competitive positioning within the evolving cannabinoid industry. A webcast and dial-in option are available.

CAE will announce its Q3 FY26 financial results on February 12, 2026. An investor conference call with the executive team is scheduled for February 13, offering a performance review and strategic outlook. The call will be available via webcast and phone. CAE is a global leader in training, simulation, and critical operations solutions, dedicated to enhancing safety and performance across aviation and defense sectors.

TTM Technologies will report its Q4 and full fiscal year 2025 financial results on Wednesday, February 4, 2026, after market close. A conference call with CEO Edwin Roks and CFO Dan Boehle will follow at 4:30 p.m. ET to discuss performance and outlook. An archived webcast will be available on their investor relations website.

Innospec will release its Q4 and full-year 2025 earnings on February 17, 2026. A conference call with leadership will follow on February 18, 2026, to discuss segment performance, profitability, cash flow, and ESG initiatives. Registration is required for the call, and a webcast will be available.

Huntington Bancshares will announce its Q4 2025 earnings on January 22, 2026, before market open. The company will provide a press release and financial data on its investor relations website. A conference call is scheduled for 9 a.m. ET to discuss results. Replays will be available.

Omeros Corporation has rescheduled its conference call to January 7, 2026, at 4:30 p.m. ET to discuss the FDA approval and upcoming U.S. launch of YARTEMLEA® on January 2, 2026. YARTEMLEA® is the first and only treatment for hematopoietic stem cell transplant-associated thrombotic microangiopathy (TA-TMA). The call will provide details on this significant milestone.

First BanCorp (FBP) will release its Q4 and full-year 2025 financial results on January 27, 2026, followed by a conference call. Investors will focus on net interest income, loan provisions, asset quality, and management’s commentary on economic conditions. Strategic initiatives, digital transformation, and capital allocation plans are also key areas of interest. A webcast and dial-in option will be available, with replays accessible afterward.

words.CSPi (NASDAQ:CSPI) will announce its fiscal 2025 fourth‑quarter and full‑year results before the market opens on Tuesday, December 16, 2025. President and CEO Victor Dellovo and CFO Gary W. Levine will host a conference call at 10:00 a.m. ET, with a live webcast on the company’s website and a replay available for a year. Investors can join by phone using access code 977008. In Q3 FY2025, CSPi posted $15.45 million in revenue, a $1.22 million operating loss, $44.27 million nine‑month revenue, $0.10 million net income and $26.31 million cash on hand.